Details for 2017183171
Up to date per 02.04.2026
Actions
Details for 2017183171
Granted/Registered
European Patent
07.03.2018 A
17.04.2019 B1
29.08.2011
US
201161528736 P
08.05.2012
US
201261644397 P
A61K 9/00 20060101AFI20171221BHEP
Owner
Mati Therapeutics Inc.4317 Dunning Lane Austin, TX 78746US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
CADDEN, Suzanne4211 Sunset Blvd North Vancouver, British Columbia V7R 3Y7CA
HAO, Yong6820 Fleming Street Vancouver, British Columbia V5P 3H5CA
UTKHEDE, DeepankMati Therapeutics (Canada) Inc. 201 - 4475 Wayburne Drive Burnaby, BC V5G 4X4CA
RUBINCHIK, Valery10493 Yarmish Drive Richmond, British Columbia V7E 5L5CA
KJELLBOTN, Charles Richard17861 68th Avenue Surrey, British Columbia V3S 9E2CA
Information about Fees